Paul Gross

Insider Reports History

Entity
Individual
Location
5500 Flatiron Parkway, Suite 100, Boulder, CO
Signature
/s/ Paul Gross
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Gross:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Clovis Oncology, Inc. Executive Vice President and General Counsel Common Stock 98.3K $96.6K $0.98 Nov 2, 2022 Direct
Clovis Oncology, Inc. Executive Vice President and General Counsel Restricted Stock Units 23.1K Nov 1, 2022 Direct

Insider Reports Filed by Paul Gross

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CLVS Clovis Oncology, Inc. Nov 1, 2022 6 -$4.65K 4 Nov 3, 2022 Executive Vice President and General Counsel
CLVS Clovis Oncology, Inc. Sep 1, 2022 3 -$2.77K 4 Sep 6, 2022 Executive Vice President and General Counsel
CLVS Clovis Oncology, Inc. Aug 1, 2022 6 -$7.02K 4 Aug 3, 2022 Executive Vice President and General Counsel
CLVS Clovis Oncology, Inc. Jun 1, 2022 3 -$1.54K 4 Jun 3, 2022 Executive Vice President and General Counsel
CLVS Clovis Oncology, Inc. May 1, 2022 6 -$9K 4 May 3, 2022 Executive Vice President and General Counsel
CLVS Clovis Oncology, Inc. Mar 1, 2022 7 -$20K 4 Mar 3, 2022 Executive Vice President and General Counsel
CLVS Clovis Oncology, Inc. Feb 1, 2022 6 -$10.5K 4 Feb 3, 2022 Executive Vice President and General Counsel
CLVS Clovis Oncology, Inc. Dec 1, 2021 3 -$744 4 Dec 3, 2021 Executive Vice President and General Counsel
CLVS Clovis Oncology, Inc. Nov 1, 2021 6 -$20.6K 4 Nov 3, 2021 Executive Vice President and General Counsel
CLVS Clovis Oncology, Inc. Sep 1, 2021 3 -$1.22K 4 Sep 3, 2021 Executive Vice President and General Counsel
CLVS Clovis Oncology, Inc. Aug 1, 2021 6 -$21.7K 4 Aug 3, 2021 Executive Vice President and General Counsel
CLVS Clovis Oncology, Inc. Jun 1, 2021 3 -$1.3K 4 Jun 3, 2021 Executive Vice President and General Counsel